Skip to main content
Signal8

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer’s disease, and Parkinson’s disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc.

OTC:RVPHOTC (suspended from Nasdaq on May 14, 2026)Healthcare
+1.30%$0.3550
CLOSED
Mkt Cap$4.65M
EV-
Float12.86M
O/S13.11M
VOL7K sh
$ Vol$3K
RVOL0.22×
Inst Own0.1%
SI3.1%
Net Cash/Sh-
Dilution
Reviva Pharmaceuticals Holdings, Inc. logoOTC:RVPHClosed$0.3550+1.30%
Short interest (FINRA)
3.1%
Oct 30 (19d)

Float 12.86M · Signal8 dilution snapshot · Nov 13, 2026

403.3K
Oct 30 (19d)prev 400.2K▲ 0.8%
6.73
Oct 30 (19d)prev 7.97▼ 15.6%
Borrow (IBKR)

The cost to borrow RVPH shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
2.5%
Nov 17 (1d)prev 28.9%▼ 26.4 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

293
Oct 29 (20d)prev 185▲ 58.4%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver22 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 2026403.3K sh
Oct 15, 2026400.2K sh
Sep 30, 2026402.0K sh
Sep 15, 2026405.1K sh
Aug 31, 2026400.3K sh
Latest fails to deliver
DateShares failed
Oct 29, 2026293 sh
Oct 6, 2026185 sh
Sep 17, 20262 sh
Sep 3, 2026252 sh
Sep 2, 2026368 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 17
Latest sessions
DateReported short
Nov 17, 20262.5%
Nov 16, 202628.9%
Nov 13, 202645.4%
Nov 12, 202624.4%
Nov 11, 202630.7%
83-session median 26.1%mean 29.6%range 0.0–87.5%

130 calendar days requested; 84 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for RVPH: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 403,277 RVPH shares were sold short (3.14% of a 12.86M-share float, 6.73 days to cover).